| GFOR Shares Outstanding History Table | ||||||||||||||||||||||||||
Also see: GFOR Market Cap History GFOR YTD Return |
| GFOR Shares Outstanding History Chart | |||||||||||||||||||||||||||
-23.29% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||
| GFOR Stock Price Chart |
| About Nkgen Biotech Inc |
| NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of autologous, allogeneic and CAR-NK Natural Killer cell therapeutics. We show 12 historical shares outstanding datapoints in our coverage of GFOR's shares outstanding history. Understanding the changing numbers of GFOR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GFOR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GFOR by allowing them to research GFOR shares outstanding history as well as any other stock in our coverage universe. |
| GFOR Current Stock Quote |
 Free GFOR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| GFOR Share Performance |
| Shares Outstanding Peers |
| Graf Acquisition IV (GFOR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GH Shares Outstanding History |
